Chesley Taft & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.2M | Buy |
42,333
+470
| +1% | +$226K | 0.83% | 35 |
|
|
2026
Q1 | $20.6M | Sell |
41,863
-579
| -1% | -$314K | 0.86% | 36 |
|
|
2025
Q4 | $24.6M | Buy |
42,442
+1,469
| +4% | +$831K | 0.97% | 28 |
|
|
2025
Q3 | $19.9M | Sell |
40,973
-494
| -1% | -$230K | 0.84% | 32 |
|
|
2025
Q2 | $16.8M | Sell |
41,467
-301
| -0.7% | -$126K | 0.75% | 38 |
|
|
2025
Q1 | $20.8M | Buy |
41,768
+1,822
| +5% | +$987K | 1% | 30 |
|
|
2024
Q4 | $20.8M | Sell |
39,946
-125
| -0.3% | -$68.7K | 0.96% | 30 |
|
|
2024
Q3 | $24.8M | Buy |
40,071
+30
| +0.1% | +$17.8K | 1.18% | 27 |
|
|
2024
Q2 | $22.1M | Buy |
40,041
+582
| +1% | +$333K | 1.11% | 26 |
|
|
2024
Q1 | $22.9M | Buy |
39,459
+20
| +0.1% | +$11.2K | 1.17% | 25 |
|
|
2023
Q4 | $20.9M | Sell |
39,439
-203
| -0.5% | -$98.3K | 1.17% | 25 |
|
|
2023
Q3 | $20.1M | Sell |
39,642
-870
| -2% | -$464K | 1.3% | 21 |
|
|
2023
Q2 | $21.1M | Sell |
40,512
-286
| -0.7% | -$154K | 1.29% | 20 |
|
|
2023
Q1 | $23.5M | Sell |
40,798
-318
| -0.8% | -$179K | 1.54% | 16 |
|
|
2022
Q4 | $22.6M | Sell |
41,116
-295
| -0.7% | -$156K | 1.56% | 17 |
|
|
2022
Q3 | $21M | Sell |
41,411
-136
| -0.3% | -$76.1K | 1.55% | 18 |
|
|
2022
Q2 | $22.6M | Sell |
41,547
-1,255
| -3% | -$691K | 1.54% | 18 |
|
|
2022
Q1 | $24.4M | Sell |
42,802
-774
| -2% | -$445K | 1.43% | 18 |
|
|
2021
Q4 | $29.1M | Sell |
43,576
-551
| -1% | -$344K | 1.5% | 17 |
|
|
2021
Q3 | $25.2M | Sell |
44,127
-142
| -0.3% | -$77.9K | 1.44% | 19 |
|
|
2021
Q2 | $22.3M | Sell |
44,269
-1,126
| -2% | -$531K | 1.28% | 21 |
|
|
2021
Q1 | $21.1M | Sell |
45,395
-461
| -1% | -$220K | 1.26% | 24 |
|
|
2020
Q4 | $21.4M | Sell |
45,856
-2,556
| -5% | -$1.2M | 1.36% | 21 |
|
|
2020
Q3 | $21.4M | Sell |
48,412
-548
| -1% | -$226K | 1.52% | 18 |
|
|
2020
Q2 | $17.7M | Sell |
48,960
-2,218
| -4% | -$743K | 1.35% | 20 |
|
|
2020
Q1 | $14.5M | Sell |
51,178
-311
| -0.6% | -$98.1K | 1.32% | 22 |
|
|
2019
Q4 | $16.7M | Sell |
51,489
-543
| -1% | -$165K | 1.2% | 27 |
|
|
2019
Q3 | $15.2M | Sell |
52,032
-402
| -0.8% | -$115K | 1.17% | 28 |
|
|
2019
Q2 | $15.4M | Buy |
52,434
+278
| +0.5% | +$76.6K | 1.2% | 27 |
|
|
2019
Q1 | $14.3M | Sell |
52,156
-2,505
| -5% | -$623K | 1.19% | 29 |
|
|
2018
Q4 | $12.2M | Sell |
54,661
-1,075
| -2% | -$252K | 1.18% | 31 |
|
|
2018
Q3 | $13.6M | Buy |
55,736
+305
| +0.6% | +$70.2K | 1.08% | 32 |
|
|
2018
Q2 | $11.5M | Sell |
55,431
-1,210
| -2% | -$257K | 0.99% | 33 |
|
|
2018
Q1 | $11.7M | Sell |
56,641
-590
| -1% | -$124K | 1.04% | 32 |
|
|
2017
Q4 | $10.9M | Buy |
57,231
+122
| +0.2% | +$23.4K | 0.92% | 32 |
|
|
2017
Q3 | $10.8M | Buy |
57,109
+4,167
| +8% | +$755K | 0.93% | 34 |
|
|
2017
Q2 | $9.24M | Sell |
52,942
-765
| -1% | -$128K | 0.83% | 39 |
|
|
2017
Q1 | $8.25M | Sell |
53,707
-1,755
| -3% | -$268K | 0.78% | 40 |
|
|
2016
Q4 | $7.83M | Buy |
55,462
+690
| +1% | +$102K | 0.77% | 42 |
|
|
2016
Q3 | $8.71M | Sell |
54,772
-1,200
| -2% | -$185K | 0.88% | 41 |
|
|
2016
Q2 | $8.27M | Sell |
55,972
-43
| -0.1% | -$6.35K | 0.85% | 41 |
|
|
2016
Q1 | $7.93M | Sell |
56,015
-678
| -1% | -$90.9K | 0.84% | 44 |
|
|
2015
Q4 | $8.04M | Sell |
56,693
-4,617
| -8% | -$616K | 0.85% | 42 |
|
|
2015
Q3 | $7.5M | Sell |
61,310
-60
| -0.1% | -$7.82K | 0.82% | 44 |
|
|
2015
Q2 | $7.96M | Sell |
61,370
-45
| -0.1% | -$5.87K | 0.81% | 45 |
|
|
2015
Q1 | $8.25M | Sell |
61,415
-3,695
| -6% | -$476K | 0.85% | 46 |
|
|
2014
Q4 | $8.16M | Buy |
65,110
+465
| +0.7% | +$56.5K | 0.82% | 46 |
|
|
2014
Q3 | $7.87M | Sell |
64,645
-370
| -0.6% | -$45K | 0.82% | 46 |
|
|
2014
Q2 | $7.67M | Buy |
65,015
+520
| +0.8% | +$61.2K | 0.79% | 49 |
|
|
2014
Q1 | $7.75M | Buy |
64,495
+3,620
| +6% | +$430K | 0.83% | 47 |
|
|
2013
Q4 | $6.78M | Sell |
60,875
-190
| -0.3% | -$18.9K | 0.68% | 50 |
|
|
2013
Q3 | $5.63M | Buy |
61,065
+75
| +0.1% | +$6.78K | 0.61% | 58 |
|
|
2013
Q2 | $5.16M | Buy |
+60,990
| New | +$5.08M | 0.6% | 58 |
|
Other funds holding TMO
RG
LT
ATO
QP
CF
Chesley Taft & Associates's TMO Position: Q2 2026 in Review
Chesley Taft & Associates increased its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, buying an estimated $226K and bringing the position to 42,333 shares worth $21.2M. The position accounts for 0.83% of the portfolio, ranked #35.
Chesley Taft & Associates first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.1M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Chesley Taft & Associates held 42,333 shares of Thermo Fisher Scientific worth $21.2M as of Q2 2026.
- Chesley Taft & Associates bought 470 Thermo Fisher Scientific shares in Q2 2026, an estimated $226K.
- Thermo Fisher Scientific made up 0.83% of Chesley Taft & Associates's portfolio in Q2 2026, its #35 holding.
- Chesley Taft & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Chesley Taft & Associates's Thermo Fisher Scientific position peaked at $29.1M in Q4 2021.
- 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.